Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 96Stomach Neoplasms 53Rectal Neoplasms 49Pancreatic Neoplasms 42Colonic Neoplasms 34Esophageal Neoplasms 30Neoplasm Metastasis 28Neoplasms 23Adenocarcinoma Of Esophagus 19Adenocarcinoma 9Parkinson Disease 4, Autosomal Dominant Lewy Body 7Lymphoma, Large B-Cell, Diffuse 7Gallbladder Neoplasms 7Biliary Tract Neoplasms 7Esophageal Squamous Cell Carcinoma 6Carcinoma, Non-Small-Cell Lung 6Ovarian Neoplasms 5Liver Neoplasms 5Head and Neck Neoplasms 5Cholangiocarcinoma 5Recurrence 4Lymphoma, Non-Hodgkin 4Gastrointestinal Neoplasms 4Carcinoma, Hepatocellular 4Breast Neoplasms 4Bile Duct Neoplasms 4Peritoneal Neoplasms 3Pancreatic Adenocarcinoma 3Leukemia 3Fallopian Tube Neoplasms 3

Interventions

Gemcitabine 2irinotecan sucrosofate 1cabiralizumab 1Oxaliplatin 1Nivolumab 1Leucovorin 1Irinotecan 1IMM-101 1Fluorouracil 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Advanced Pancreatic Cancer × Oxaliplatin × Clear all
NCT03336216 2024-07-23

A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer

Bristol-Myers Squibb

Phase 2 Completed
205 enrolled 30 charts
Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡